Upload Image (Max 20MB per Image)
Boehringer Ingelheim has submitted European marketing authorization applications (MAA) to extend the indication to use tiotropium (Spiriva) Respimat for the treatment of asthma in adults aged 18 years and over. The MAA is based on results ...
Tags: Boehringer Ingelheim, Tiotropium Respimat